Racial differences in a prostate cancer screening study

Journal of Urology

Volumn 156, Issue 4, 1996, Pages 1366-1369

  Smith, Deborah S ^a   Bullock, Arnold D ^a   Catalona, William J ^a   Herschman, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE;

EID: 0029814918     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65588-5     Document Type: Article

References (21)

1. Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L. and Edwards, B. K.: Cancer Statistics Review: 1973-1989. Bethesda, Maryland: National Cancer Institute, 1992.
2. Polednak, A. P. and Flannery, J. T.: Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer, 70: 2152, 1992.
3. Steele, G. D., Jr., Osteen, R. T., Winchester, D. P., Murphy, G. P. and Menck, H. R.: Clinical highlights from the National Cancer Data Base: 1994. CA, 44: 71, 1994.
4. Roach, M., III, Krall, J., Keller, J. W., Perez, C. A., Sause, W. T., Doggett, R. L., Rotman, M., Russ, H., Pilepich, M. V., Asbell, S. O. and Shipley, W.: The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int. J. Rad. Oncol. Biol. Phys., 24: 441, 1992.
5. Price, J. H., Colvin, T. L. and Smith, D.: Prostate cancer: perceptions of African-American males. J. Natl. Med. Ass., 85: 941, 1993.
6. Taylor, J. D., Holmes, T. M. and Swanson, G. M.: Descriptive epidemiology of prostate cancer in metropolitan Detroit. Cancer, 73: 1704, 1994.
7. Austin, J. P., Aziz, H., Potters, L., Thelmo, W., Chen, P., Choi, K, Brandys, M., Macchia, R. J. and Rotman, M.: Diminished survival of young blacks with adenocarcinoma of the prostate. Amer. J. Clin. Oncol., 13: 465, 1990.
8. Mettlin, C., Murphy, G. P. and Menck, H.: Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Data-base, 1985-1990. Urology, 43: 488, 1994.
9. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
10. Demark-Wahnefried, W., Strigo, T., Catoe, K., Conaway, M., Brunetti, M., Rimer, B. K. and Robertson, C. N.: Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology, 46: 346, 1995.
11. Catalona, W. J. and Bigg, S. W.: Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J. Urol., 143: 538, 1990.
12. Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
13. Katz, S. J. and Hofer, T. P.: Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical screening in Ontario and the United States. J.A.M.A., 272: 530, 1994.
14. Hosmer, D. W., Jr. and Lemeshow, S.: Applied Logistic Regression. New York: John Wiley & Sons, pp. 17-18 and 54, 1989.
15. Breslow, N., Chan, C. W., Dhom, G., Drury, R. A., Franks, L. M., Gellei, B., Lee, Y. S., Lundberg, S., Sparke, B., Sternby, N. H. and Tulinius, H.: Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer, 20: 680, 1977.
16. Guileyardo, J. M., Johnson, W. D., Welsh, R. A., Akazaki, K. and Correa, P.: Prevalence of latent prostate carcinoma in two U.S. populations. J. Natl. Cancer Inst., 65: 311, 1980.
17. Whittemore, A. S., Keller, J. B. and Betensky, R.: Low-grade, latent prostate cancer volume: predictor of clinical cancer incidence? J. Natl. Cancer Inst., 83: 1231, 1991.
18. Vijayakumar, S., Karrison, T., Weichselbaum, R. R., Chan, S., Quadri, S. F. and Awan, A. M.: Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol. Biomarkers Prev., 1: 541, 1992.
19. Baquet, C. R., Horm, J. W., Gibbs, T. and Greenwald, P.: Socioeconomic factors and cancer incidence among blacks and whites. J. Natl. Cancer Inst., 83: 551, 1991.
20. Boring, C. C., Squires, T. S., Tong, T. and Montgomery, S.: Cancer statistics, 1994. CA, 44: 7, 1994.
21. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. J.A.M.A., 274: 1599, 1995.